| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 06/22/2006 | US20060134740 Engineered proteases for affinity purification and processing of fusion proteins |
| 06/22/2006 | US20060134738 Gene expression inducing fusion protein and method for controlling gene expression Induction |
| 06/22/2006 | US20060134737 Ubiquitinated TNF receptor2 and its uses |
| 06/22/2006 | US20060134722 Method and compositions for detecting botulinum neurotoxin |
| 06/22/2006 | US20060134719 Novel serine protease |
| 06/22/2006 | US20060134717 Method for making biochips |
| 06/22/2006 | US20060134689 Real-time polymerase chain reaction-based genotyping assay for single nucleotide polymorphism |
| 06/22/2006 | US20060134682 Preparation and use of superior vaccines |
| 06/22/2006 | US20060134680 Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof |
| 06/22/2006 | US20060134675 Immobilizing the reaction product of a polyethylene glycol and a hydrolyzed maleic anhydride copolymer-containing hydrogel on a substrate, adding a mixture of a salt and nucleic acids to bind the nucleic acids to the hydrogel, washing the hydrogel, and eluting the nucleic acid from the hydrogel |
| 06/22/2006 | US20060134673 Diagnostic assay for Wiskott-Aldrich syndrome and genetically related disorders |
| 06/22/2006 | US20060134672 Macromolecular arrays on polymeric brushes & methods for preparing the same |
| 06/22/2006 | US20060134658 Use of RNA trans-splicing for generation of interfering RNA molecules |
| 06/22/2006 | US20060134649 Bardet-Biedl susceptibility gene and uses thereof |
| 06/22/2006 | US20060134648 One-tube nested PCR for detecting mycobacterium tuberculosis |
| 06/22/2006 | US20060134643 Bisulfite conversion of DNA |
| 06/22/2006 | US20060134642 Pharmacological targeting of bacterial DNA ligase for treatment and prevention of bacterial infections |
| 06/22/2006 | US20060134634 Human gene |
| 06/22/2006 | US20060134633 Double ended sequencing |
| 06/22/2006 | US20060134627 Oligonucleotide primers and polynucleotide probes that provide selective amplification and detection of Id genetic sequences |
| 06/22/2006 | US20060134626 Process for extracting nucleic acid |
| 06/22/2006 | US20060134623 Novel compositions and methods in cancer |
| 06/22/2006 | US20060134621 Diagnostic test for attention deficit hyperactivity disorder |
| 06/22/2006 | US20060134620 Method and apparatus for concentration and purification of nucleic acid |
| 06/22/2006 | US20060134619 Casein kinase i epsilon and casein kinase i delta and sleep in humans |
| 06/22/2006 | US20060134618 Detection, identification and differentiation of eubacterial taxa using a hybridization assay |
| 06/22/2006 | US20060134610 Chris-like virus, compositions, vaccines and uses thereof |
| 06/22/2006 | US20060134609 Compositions and methods for determining the presence of SARS coronavirus in a sample |
| 06/22/2006 | US20060134266 Enzyme |
| 06/22/2006 | US20060134189 siRNA silencing of apolipoprotein B |
| 06/22/2006 | US20060134122 Peptides of syndecan-1 for inhibition of cancer |
| 06/22/2006 | US20060134117 Preventives/remedies for cancer |
| 06/22/2006 | US20060134116 Ca 125 tumor antigen function and uses thereof |
| 06/22/2006 | US20060134114 Novel human kallikrein-like genes |
| 06/22/2006 | US20060134109 G protein coupled receptors and uses thereof |
| 06/22/2006 | CA2634589A1 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising this fragment for detecting, preventing, and treating hiv |
| 06/22/2006 | CA2591918A1 Cancer-specific spanx-n markers |
| 06/22/2006 | CA2590935A1 Fc.gamma.riib-specific antibodies and methods of use thereof |
| 06/22/2006 | CA2590768A1 Rnai modulation of mll-af4 and uses thereof |
| 06/22/2006 | CA2590619A1 Casein kinase 2 antisense therapy |
| 06/22/2006 | CA2590221A1 Synthesis of phosphitylated compounds using a quaternary heterocyclic activator |
| 06/22/2006 | CA2589553A1 Use of flagellin in the immunotherapy of yersinia pestis |
| 06/22/2006 | CA2587285A1 Actinomadura chromoprotein, apoprotein, and gene cluster |
| 06/21/2006 | EP1672072A2 Cloning and characterisation of the gene flbA of H. pylori; production of flagella-free strains |
| 06/21/2006 | EP1671116A2 Novel antisense oligomers and use thereof |
| 06/21/2006 | EP1671097A2 Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins |
| 06/21/2006 | EP1670955A2 Synthetic lethal screen using rna interference |
| 06/21/2006 | EP1670954A2 Methods for risk assessment, survival prediction and treatment of heart failure and other conditions based on adrenergic receptor polymorphisms |
| 06/21/2006 | EP1670953A2 Primers for use in detecting beta-lactamases |
| 06/21/2006 | EP1670952A2 Methods for identifying a biosynthetic pathway gene product |
| 06/21/2006 | EP1670931A2 Method for the production of fusion proteins in transgenic mammal milk |
| 06/21/2006 | EP1670928A2 Single nucleotide polymorphism analysis of highly polymorphic target sequences |
| 06/21/2006 | EP1670915A2 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 06/21/2006 | EP1670898A2 Microfluidic rotary flow reactor matrix |
| 06/21/2006 | EP1670896A2 Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry |
| 06/21/2006 | EP1670822A2 Igf binding proteins |
| 06/21/2006 | EP1670810A2 Gapped oligomeric compounds having linked bicycli csugar moieties at the termini |
| 06/21/2006 | EP1670518A1 Rna interference for the treatment of gain-of-function disorders |
| 06/21/2006 | EP1670350A2 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 06/21/2006 | EP1670307A2 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs |
| 06/21/2006 | EP1629095A4 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
| 06/21/2006 | EP1540003A4 Methods and composition for detecting targets |
| 06/21/2006 | EP1007089B1 Anticoagulant humanised antibodies against factor IX, for use in the treatment of thrombosis |
| 06/21/2006 | EP0830456B1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE |
| 06/21/2006 | EP0754231B1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 06/21/2006 | EP0723663B1 Hybridoma and anti-kc-4 humanised monoclonal antibody, dna and rna encoding it, kit and diagnostic methods |
| 06/21/2006 | CN1791683A Markers for LXR activation |
| 06/21/2006 | CN1791682A Random array DNA analysis by hybridization |
| 06/21/2006 | CN1791681A Methods to increase nucleotide signals by raman scattering |
| 06/21/2006 | CN1791509A Methods and apparatus for pathogen detection and analysis |
| 06/21/2006 | CN1791433A DNA vaccines against tumor growth and methods of use thereof |
| 06/21/2006 | CN1789411A Isolated nucleic acid molecules which encode T cell inducible factors (TIF), the proteins encoded, and uses thereof |
| 06/21/2006 | CN1260361C Inhibition of Ii synthesis |
| 06/21/2006 | CN1260349C Streptomyces nanningensis |
| 06/21/2006 | CN1260242C Method for extracting DNA by using magnetic nano composite material and its kit |
| 06/21/2006 | CN1260241C Core protein glycan-preparing method |
| 06/20/2006 | US7064197 A non-porous solid support containing one or more amine(s), hydroxyl(s) or epoxide(s) thereon, and a single-stranded nucleic acid is fixed or immobilized in hybridizable form to such support via one or more amine(s), hydroxyl(s) or epoxide(s); useful for nucleic acid detection and quantification |
| 06/20/2006 | US7064196 Genes encoding carotenoid compounds |
| 06/20/2006 | US7064195 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 06/20/2006 | US7064194 Vectors for animal cells and utilization thereof |
| 06/20/2006 | US7064190 An isolated complex of a peptide of glutamic acid decarboxylase(with specific 6 contiguous amino acids), and an allele of MHC class II molecules DR3 and DR4; useful for diagnosis and therapy of autoimmune diseases |
| 06/20/2006 | US7063978 Coated film laminate having an electrically conductive surface |
| 06/20/2006 | US7063973 HDAC9 polypeptides and polynucleotides and uses thereof |
| 06/20/2006 | US7063972 Cytochrome P450 monooxygenase CYP52A2A from Candida tropicalis |
| 06/20/2006 | US7063965 especially that encodes an immunoglobulin constant region such as the Fc portion of human IgG1. |
| 06/20/2006 | US7063963 Nucleotide sequences consisiting of DNA viral open reading frames which code proteins which can be used to prepare genetic vaccines which prevent viral diseases |
| 06/20/2006 | US7063962 DNA sequences for regulating transcription |
| 06/20/2006 | US7063960 Interacting the immature dendritic cels with an antigen ex vivo so that the surface antigen is presented; inducing maturation ex vivo; and contacting with a modulator comprising TRANCE or derivative |
| 06/20/2006 | US7063959 nucleic acids encoding SOC/CRAC calcium channel polypeptides that play an important role in the influx of extracellular calcium by mediating the refilling of intracellular calcium stores following their depletion |
| 06/20/2006 | US7063958 that encode a receptor for leptin, including a naturally occurring soluble form of the receptor that is expected to modulate, especially agonize, leptin activity; could be used to treat obesity |
| 06/20/2006 | US7063955 Genes have been isolated from Rhodococcus and Deinococcus which encode a specific lycopene beta -cyclase capable of converting acyclic carotenoids with atleast one psi-end group to corresponding asymetric caratenoid |
| 06/20/2006 | US7063945 To be used in hybridization methods, for the determination of a nucleic acid |
| 06/20/2006 | US7063944 Human methionine synthase reductase: cloning, and methods for evaluating risk of, preventing, or treating neural tube defects, cardiovascular disease, cancer, and down's syndrome |
| 06/20/2006 | US7063943 Methods for producing members of specific binding pairs |
| 06/20/2006 | US7063853 DNA immunization against Chlamydia infection |
| 06/20/2006 | US7063840 Genes for receptor tyrosine kinases and their cognate ligands, their insertion into genetic engineered DNA vectors; useful in the diagnosis and treatment of neoplastic diseases |
| 06/15/2006 | WO2006063356A1 Regulation of epigenetic control of gene expression |
| 06/15/2006 | WO2006063065A2 Detection of nucleic acids from multiple types of human papillomaviruses |
| 06/15/2006 | WO2006062684A2 Populations of reporter sequences and methods of their use |
| 06/15/2006 | WO2006060872A1 Human papilloma virus (hpv) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (facs) |